1-7 of 7
Janina Jablonski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials

Free
Angie Mae Rodday, Dennis Eichenauer, Janina Jablonski, Sven Borchmann, Hocine Tighiouart, Jenica Upshaw, David Hodgson, Matthew Maurer, Nicholas Counsell, Sara Rossetti, Zhu Cui, Ranjana Advani, Marc Andre, Massimo Federico, Annette Hay, Richard Hoppe, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, Kerry Savage, John Radford, James Cerhan, Peter Borchmann, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 1845.
https://doi.org/10.1182/blood-2025-1845
Published: 2025
Journal Articles

Final analysis of the Phase III GHSG HD21 trial: PET-guided brecadd vs. ebeacopp in advanced-stage classical Hodgkin lymphoma

Free
Justin Ferdinandus, Helen Kaul, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Hänel, Urban Novak, Julia Meissner, Johannes Hellmuth, Stephan Mathas, Josée Zijlstra, Alexander Fosså, Andreas Viardot, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel Molin, Janina Jablonski, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Markus Dietlein, Carsten Kobe, Bastian von Tresckow, Peter Borchmann
Journal: Blood
Blood (2025) 146 (Supplement 1): 152.
https://doi.org/10.1182/blood-2025-152
Published: 2025
Journal Articles

Effects of antibiotic prophylaxis in first-line therapy of advanced stage classic Hodgkin lymphoma: An analysis of the GHSG HD21 study

Free
Hishan Tharmaseelan, Janina Jablonski, Gundolf Schneider, Helen Kaul, Christian Jaworek, Anne Sophie Robertz, Justin Ferdinandus, Michael Fuchs, Paul Bröckelmann, Jannik Stemler, Peter Borchmann
Journal: Blood
Blood (2025) 146 (Supplement 1): 3626.
https://doi.org/10.1182/blood-2025-3626
Published: 2025
Journal Articles

Patient-Reported Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classical Hodgkin Lymphoma Treated with BrECADD and eBEACOPP in the HD21 Trial

Free
Fjoralba Kristo, Flora Mazerolle, Thibaud Alin, Antoine Regnault, Justin Ferdinandus, Karolin Behringer, Janina Jablonski, Peter Borchmann, Ajibade Ashaye
Journal: Blood
Blood (2024) 144 (Supplement 1): 1662.
https://doi.org/10.1182/blood-2024-200211
Published: 2024
Journal Articles

Estimation of Health State Utility Values for Patients Undergoing First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the HD21 Trial

Free
Christopher G. Pelligra, Fjoralba Kristo, Yutian Mu, Justin Ferdinandus, Karolin Behringer, Janina Jablonski, Peter Borchmann, Ajibade Ashaye
Journal: Blood
Blood (2024) 144 (Supplement 1): 2346.
https://doi.org/10.1182/blood-2024-200133
Published: 2024
Journal Articles

Impact of Treatment-Related Morbidity on Health-Related Quality of Life in Patients with Advanced-Stage Classical Hodgkin Lymphoma Receiving Multiagent Therapy: Findings from the HD21 Study

Free
Fjoralba Kristo, Flora Mazerolle, Thibaud Alin, Antoine Regnault, Justin Ferdinandus, Karolin Behringer, Janina Jablonski, Peter Borchmann, Ajibade Ashaye
Journal: Blood
Blood (2024) 144 (Supplement 1): 4426.
https://doi.org/10.1182/blood-2024-200233
Published: 2024
Journal Articles

Patterns of Disease in Early Stage Favorable Hodgkins Lymphoma

Free
Hishan Tharmaseelan, Janina Jablonski, Ina Bühnen, Johannes Rosenbrock, Paul J. Bröckelmann, Justin Ferdinandus, Peter Borchmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 3050.
https://doi.org/10.1182/blood-2024-200035
Published: 2024